Immuron (IMRN) Accounts Payables (2016 - 2025)
Immuron (IMRN) posted quarterly Accounts Payables of $15294.3 for Q3 2025, down 28.39% year-over-year from $21358.5 in Q3 2024, and down 98.44% quarter-over-quarter from $979501.0 in Q2 2025.
Immuron (IMRN) Accounts Payables (2016 - 2025) Analysis & Trends
Immuron's Accounts Payables history runs 10 years deep, the most recent figure standing at $15294.3 for Q3 2025.
- In Q3 2025, Accounts Payables fell 28.39% year-over-year to $15294.3; the TTM figure through Sep 2025 stood at $15294.3 (down 28.39% YoY), while the FY2025 annual figure was $15294.3, down 28.39% from the prior year.
- Accounts Payables for Q3 2025 stood at $15294.3, down from $979501.0 in the prior quarter.
- The five-year high for Accounts Payables was $1.4 million in Q2 2024, with the low at $10838.7 in Q4 2023.
- The 5-year median for Accounts Payables is $772284.0 (2023), against an average of $600602.8.
- The sharpest annual moves came in 2021 and 2023: Accounts Payables soared 23210.63% in 2021, then slumped 98.58% in 2023.
- Immuron's Accounts Payables stood at $555231.3 in 2021, then surged by 37.37% to $762732.0 in 2022, then plunged by 98.58% to $10838.7 in 2023, then jumped by 7668.8% to $842036.5 in 2024, then tumbled by 98.18% to $15294.3 in 2025.
- Business Quant data shows IMRN's Accounts Payables at $15294.3 in Q3 2025, $979501.0 in Q2 2025, and $842036.5 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 35.57 Mn |
| 10 | Immuron | 6.64 Mn | 6.61 Mn | - | 15,294.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 15,294.34 |
| Jun 30, 2025 | 979,500.96 |
| Dec 31, 2024 | 842,036.48 |
| Sep 9, 2024 | 21,358.52 |
| Jun 30, 2024 | 1.41 Mn |
| Dec 31, 2023 | 10,838.70 |
| Sep 28, 2023 | 781,835.96 |
| Aug 30, 2023 | 11,927.69 |
| Jun 30, 2023 | 797,199.62 |
| Dec 31, 2022 | 762,732.01 |
| Aug 31, 2022 | 807,311.55 |
| Jun 30, 2022 | 831,510.88 |
| Dec 31, 2021 | 555,231.32 |
| Jun 30, 2021 | 584,082.20 |
| Dec 31, 2020 | 2,381.88 |
| Sep 1, 2020 | 384,397.00 |
| Jun 30, 2020 | 251,941.72 |
| Dec 31, 2019 | 3,843.97 |
| Jun 30, 2019 | 764,858.99 |
| Dec 31, 2018 | 689,326.00 |